Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03443440 · ClinicalTrials.gov registry record
Prognostic Factors Associated With Postoperative Cognitive Dysfunction After Surgery
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT03443440: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT03443440 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03443440 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
A longitudinal observational study examining preoperative, intraoperative and postoperative factors associated with Postoperative Cognitive Dysfunction in patients older than the age of 50.
Primary Outcome
Neurocognitive Test. Detection Task (Score: normal - abnormal), One Card Learning Task (Score: normal - abnormal) One Back Task (Score normal - abnormal) Identification Task (Score normal - Abnormal) Scores are based on normal distributed population data. Scores are measured on a linear scale with no maximum score. Research subjects will also act as their own control based on baseline performance in this longitudinal study.
Interventions
- OTHER Neurocognitive Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2020-06-06 |
What the finished NCT03443440 record still lists
NCT03443440 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Neurocognitive Testing is the first listed.
NCT03443440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03443440 about?
NCT03443440 is a clinical study titled "Prognostic Factors Associated With Postoperative Cognitive Dysfunction After Surgery". A longitudinal observational study examining preoperative, intraoperative and postoperative factors associated with Postoperative Cognitive Dysfunction in patients older than the age of 50.
What is the current status of trial NCT03443440?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2018-04-01. Estimated completion is 2020-06-06.
What interventions are being tested in trial NCT03443440?
The interventions under investigation include: Neurocognitive Testing (OTHER).
Who is sponsoring clinical trial NCT03443440?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI